We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CPIX market cap is 78.4M. The company's latest EPS is USD -0.4331 and P/E is -12.10.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.35M | 8.5M | 9.85M | 9.09M | 10.44M |
| Operating Income | -6.18M | -1.87M | -1.03M | -1.7M | -1.84M |
| Net Income | -6.29M | -1.95M | -1.09M | -1.54M | -1.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 37.44M | 35.99M | 42.01M | 39.55M | 37.87M |
| Operating Income | -6.38M | -7.68M | -5.71M | -9.56M | -6.43M |
| Net Income | -3.34M | -3.51M | -5.57M | -6.28M | -6.48M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 81.78M | 81.51M | 78.52M | 76.75M | 75.58M |
| Total Liabilities | 52.52M | 54.32M | 52.49M | 52.28M | 53.04M |
| Total Equity | 29.26M | 27.19M | 26.03M | 24.47M | 22.55M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 96.46M | 84.46M | 92.93M | 81.78M | 75.58M |
| Total Liabilities | 49.59M | 41.86M | 56.95M | 52.52M | 53.04M |
| Total Equity | 46.87M | 42.6M | 35.97M | 29.26M | 22.55M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 6.09M | -2.14M | -2.99M | -2.52M | -612k |
| Investing | -106k | -59k | -105k | 85k | 58k |
| Financing | -7.42M | 2.42M | 2.11M | 1.58M | 197k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 5.42M | 6.34M | 8.45M | 6.09M | -612k |
| Investing | -1.76M | -502k | -13.67M | -106k | 58k |
| Financing | -7.12M | -3.55M | -2.06M | -7.42M | 197k |
| Market Cap | 78.4M |
| Price to Earnings Ratio | -12.10 |
| Price to Sales Ratio | 2.07 |
| Price to Cash Ratio | 4.36 |
| Price to Book Ratio | 3.48 |
| Dividend Yield | - |
| Shares Outstanding | 14.96M |
| Average Volume (1 week) | 37.28k |
| Average Volume (1 Month) | 38.83k |
| 52 Week Change | 258.90% |
| 52 Week High | 7.25 |
| 52 Week Low | 1.04 |
| Spread (Intraday) | 1.32 (20.47%) |
| Company Name | Cumberland Pharmaceutical Inc |
| Address |
2525 west end avenue nashville, tennessee 37203 |
| Website | https://www.cumberlandpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
